Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Kwon

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Pediatric Neurology|February 11, 2014
Intraoperative electroencephalography predicts postoperative seizures in infants with congenital heart diseaseLaurie E Seltzer, Michael Swartz, Jennifer M Kwon, et al.
Journal of Child Neurology|July 11, 2013
Classification and natural history of the neuronal ceroid lipofuscinosesJonathan W Mink, Erika F Augustine, Heather R Adams, et al.
Journal of Genetic Counseling|January 10, 2024
Development and assessment of educational materials for spinal muscular atrophy carrier screening in the Plain communityCarly Eichten, Ashley Kuhl, Mei Baker, et al.
Neuroscience Letters|August 10, 2005
Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotypeJennifer M Kwon, Paul G Rothberg, Adam R Leman, et al.
Pediatric Dermatology|December 29, 2025
KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVMDonglin Zhang, Jennifer M Kwon, Beverly Aagaard-Kienitz, et al.
Muscle & Nerve|July 1, 2021
Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophyElizabeth A Kichula, Crystal M Proud, Michelle A Farrar, et al.
Pediatrics in Review|March 3, 2007
Index of suspicionRaemma Paredes Luck, Mitra Ahmad Soltani, Juan F Villalona, et al.
Advances in Therapy|February 20, 2026
Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case SeriesMelissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, et al.
BMC Neurology|July 7, 2025
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case seriesMelissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, et al.
International Journal of Neonatal Screening|March 27, 2026
Trends in the Timeliness of Spinal Muscular Atrophy Detection in US Infants, 2016-2023Scott D Grosse, Kai Hong, Golriz K Yazdanpanah, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Pediatric Neurology|February 11, 2014
Intraoperative electroencephalography predicts postoperative seizures in infants with congenital heart diseaseLaurie E Seltzer, Michael Swartz, Jennifer M Kwon, et al.
Journal of Child Neurology|July 11, 2013
Classification and natural history of the neuronal ceroid lipofuscinosesJonathan W Mink, Erika F Augustine, Heather R Adams, et al.
Journal of Genetic Counseling|January 10, 2024
Development and assessment of educational materials for spinal muscular atrophy carrier screening in the Plain communityCarly Eichten, Ashley Kuhl, Mei Baker, et al.
Neuroscience Letters|August 10, 2005
Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotypeJennifer M Kwon, Paul G Rothberg, Adam R Leman, et al.
Pediatric Dermatology|December 29, 2025
KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVMDonglin Zhang, Jennifer M Kwon, Beverly Aagaard-Kienitz, et al.
Muscle & Nerve|July 1, 2021
Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophyElizabeth A Kichula, Crystal M Proud, Michelle A Farrar, et al.
Pediatrics in Review|March 3, 2007
Index of suspicionRaemma Paredes Luck, Mitra Ahmad Soltani, Juan F Villalona, et al.
Advances in Therapy|February 20, 2026
Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case SeriesMelissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, et al.
BMC Neurology|July 7, 2025
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case seriesMelissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, et al.
International Journal of Neonatal Screening|March 27, 2026
Trends in the Timeliness of Spinal Muscular Atrophy Detection in US Infants, 2016-2023Scott D Grosse, Kai Hong, Golriz K Yazdanpanah, et al.
Pageof 5